Boston Scientific’s Promising Trial Outcomes and Market Expansion Drive Buy Rating
Boston Scientific (BSX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Marie ...
Optimistic Buy Rating for Masimo Driven by Strong Q4 Performance and Promising 2025 Outlook
Marie Thibault, an analyst from BTIG, maintained the Buy rating on Masimo (MASI – Research Report). The associated price target remains the ...